Literature DB >> 15786415

Phenotypic variability in myotonia congenita.

Eskild Colding-Jørgensen1.   

Abstract

Myotonia congenita is a hereditary chloride channel disorder characterized by delayed relaxation of skeletal muscle (myotonia). It is caused by mutations in the skeletal muscle chloride channel gene CLCN1 on chromosome 7. The phenotypic spectrum of myotonia congenita ranges from mild myotonia disclosed only by clinical examination to severe and disabling myotonia with transient weakness and myopathy. The most severe phenotypes are seen in patients with two mutated alleles. Heterozygotes are often asymptomatic but for some mutations heterozygosity is sufficient to cause pronounced myotonia, although without weakness and myopathy. Thus, the phenotype depends on the mutation type to some extent, but this does not explain the fact that severity varies greatly between heterozygous family members and may even vary with time in the individual patient. In this review, existing knowledge about phenotypic variability is summarized, and the possible contributing factors are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15786415     DOI: 10.1002/mus.20295

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  47 in total

1.  Case 12: my doctor says that I have ALS!

Authors:  Robin K Wilson; Vinay Chaudhry
Journal:  MedGenMed       Date:  2006-03-22

2.  Functional complementation of truncated human skeletal-muscle chloride channel (hClC-1) using carboxyl tail fragments.

Authors:  Weiping Wu; Grigori Y Rychkov; Bernard P Hughes; Allan H Bretag
Journal:  Biochem J       Date:  2006-04-01       Impact factor: 3.857

3.  In vitro analysis of splice site mutations in the CLCN1 gene using the minigene assay.

Authors:  Gianna Ulzi; Valeria A Sansone; Francesca Magri; Stefania Corti; Nereo Bresolin; Giacomo P Comi; Sabrina Lucchiari
Journal:  Mol Biol Rep       Date:  2014-01-23       Impact factor: 2.316

4.  Sequence CLCN1 and SCN4A in patients with Nondystrophic myotonias in Chinese populations: Genetic and pedigree analysis of 10 families and review of the literature.

Authors:  Xinglong Yang; Hua Jia; Ran An; Jing Xi; Yanming Xu
Journal:  Channels (Austin)       Date:  2016-07-14       Impact factor: 2.581

5.  Elevation of extracellular osmolarity improves signs of myotonia congenita in vitro: a preclinical animal study.

Authors:  Kerstin Hoppe; Sunisa Chaiklieng; Frank Lehmann-Horn; Karin Jurkat-Rott; Scott Wearing; Werner Klingler
Journal:  J Physiol       Date:  2018-11-20       Impact factor: 5.182

6.  New immunohistochemical method for improved myotonia and chloride channel mutation diagnostics.

Authors:  Olayinka Raheem; Sini Penttilä; Tiina Suominen; Mika Kaakinen; James Burge; Andrea Haworth; Richa Sud; Stephanie Schorge; Hannu Haapasalo; Satu Sandell; Kalervo Metsikkö; Michael Hanna; Bjarne Udd
Journal:  Neurology       Date:  2012-11-14       Impact factor: 9.910

7.  Nondystrophic myotonia: challenges and future directions.

Authors:  Jaya R Trivedi; Stephen C Cannon; Robert C Griggs
Journal:  Exp Neurol       Date:  2013-12-18       Impact factor: 5.330

Review 8.  The preoperative neurological evaluation.

Authors:  John Probasco; Bogachan Sahin; Tung Tran; Tae Hwan Chung; Liana Shapiro Rosenthal; Zoltan Mari; Michael Levy
Journal:  Neurohospitalist       Date:  2013-10

Review 9.  Skeletal muscle channelopathies: new insights into the periodic paralyses and nondystrophic myotonias.

Authors:  Daniel Platt; Robert Griggs
Journal:  Curr Opin Neurol       Date:  2009-10       Impact factor: 5.710

10.  Novel CLCN1 mutations and clinical features of Korean patients with myotonia congenita.

Authors:  In-Soo Moon; Hyang-Sook Kim; Jin-Hong Shin; Yeong-Eun Park; Kyu-Hyun Park; Yong-Bum Shin; Jong Seok Bae; Young-Chul Choi; Dae-Seong Kim
Journal:  J Korean Med Sci       Date:  2009-11-09       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.